Mesothelioma Treatment Articles & Science Papers...

Mesothelioma Research has been established to provide you with as much in-depth and relevant information about mesothelioma, asbestos, and health related issues as possible. Here you'll find hundreds of mesothelioma & asbestos related articles collected from around the internet's major news sources and leading science publications to aid you in your research....

Salmedix Completes $45 Million Series C Financing

PR Newswire - March 30, 2004

SAN DIEGO, March 30 /PRNewswire/ -- Salmedix, Inc. announced today that it has completed the sale of $45 million of its Series C Preferred Stock.

New investor HIG Ventures led the round. Other new investors, OrbiMed Advisors, Easton Hunt Capital Partners, Hunt Ventures, Novo A/S, Quilvest Capital and Clariden Bank, joined in the financing, along with the existing Series A and B investors, InterWest Partners, Versant Ventures, Alexandria Equities, CMEA Ventures, Delphi Ventures, ProQuest Investments, Ventures West, Aberdare Partners, GeneChem Therapeutics and BioFrontier Global Investment Partnership.

Aaron Davidson, Managing Director of HIG Ventures, and Sam Wertheimer, Ph. D., Principal of OrbiMed Advisors, have joined the Board of Directors.

"We expect this investment to provide Salmedix with adequate capital to advance our three clinical-stage products, including our lead investigational drug, SDX-105, which is currently being evaluated in a Phase II/III clinical program with non-Hodgkin's lymphoma patients," said David S. Kabakoff, Ph. D., Chairman & CEO.

"HIG Ventures has selected Salmedix as the first life science investment we have led," said Aaron Davidson. "We were attracted by the company's track record of identifying promising clinical oncology products, coupled with a strong execution-focused management team."

About Salmedix

Salmedix, Inc. is developing promising oncology drugs, with an initial commercial focus on hematologic cancers. In addition to SDX-105, Salmedix has two drugs in Phase II clinical development, as well as several preclinical product candidates. A multi-center, multi-national Phase Ib/II study in patients with chronic lymphocytic leukemia was recently completed with SDX-101, a "first-in-class" compound. SDX-102, a targeted therapy for molecularly defined tumors, is in a Phase II trial to investigate its potential as a treatment for non-small cell lung cancer, pancreatic cancer, sarcoma, and mesothelioma. Salmedix's experienced team of "drug hunters" continues to identify, and will develop, additional clinical-stage cancer therapeutics.

For more information about Salmedix, please visit http://www.salmedix.com/ or contact:

Anita Busquets, Chief Financial and Administrative Officer, (858) 622-5050

David Kabakoff, Ph.D., Chairman and Chief Executive Officer, (858) 622-5050

CONTACT: David S. Kabakoff, Ph.D., Chairman & Chief Executive Officer, dkabakoff@salmedix.com, or Anita I. Busquets, Chief Financial & Administrative Officer, anitab@salmedix.com, both of Salmedix, Inc., +1-858-622-5050

Web site: http://www.salmedix.com/

Interesting Mesothelioma, Asbestos Health, & Cancer Related Discussions

Risks of Colonoscopy (13 posts)
by J - Last post on: 12-17-03 11:24
As previously posted by Orac .... From this newsgroup's Google archives. J "My first advice would be to relax. Colonoscopy is generally quite safe, but, like any other medical procedure, is not without its risks. The main risk is the small chance of causing a perfo... (Read More)

Re: Question about estrogen suppresion in post-menopausal women (1 posts)
by Steph - Last post on: 09-01-03 16:08
"Hobo" wrote in message news:noemail-D0EF15.00063101092003@cnews.newsguy.com... > > Hello, > > My mother died a few weeks ago, but I still have some questions about > the medical care she recieved. She was initially diagnosed with breast > cancer and given estrogen... (Read More)

Re: New anticancer remrdy (2 posts)
by J - Last post on: 08-22-03 09:40
Anth wrote: > http://www.abqtrib.com/cancer/index.shtml You have read up, of course, about Lymphoma? This has nothing to do with the type of cancer your mother had, Anth. J ... (Read More)